Henry Ward Wolff

Henry Ward Wolff has an estimated net worth of $5.39 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., SANGAMO BIOSCIENCES INC, Calithera Biosciences, Inc., SUNESIS PHARMACEUTICALS INC, NUVELO INC, PORTOLA PHARMACEUTICALS INC, and ABGENIX INC.

2015 was Henry Ward Wolff's most active year for acquiring shares with 24 total transactions. Henry Ward Wolff's most active month to acquire stocks was the month of May. 2013 was Henry Ward Wolff's most active year for disposing of shares, totalling 25 transactions. Henry Ward Wolff's most active month to dispose stocks was the month of February. 2008 saw Henry Ward Wolff paying a total of $382,200.00 for 330,000 shares, this is the most they've acquired in one year. In 2014 Henry Ward Wolff cashed out on 246,008 shares for a total of $2,852,805.30, their largest year based on trade value.